PReS-FINAL-2030: Treatment with leflunomide results in a higher flare rate of chronic uveitis compared to methotrexate in patients with juvenile idiopathic arthritis treated with b...

Por Bichler, J, Krumrey-Langkammerer, M, Haas, JP, Hugle, B
Publicado em 2013

PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis

Por Hugle, B, Olsson, M, Fischer, N, Herrmann, M, Lindblad-Toh, K, Haas, JP
Publicado em 2013

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)

Por Bielak, M., Husmann, E., Weyandt, N., Haas, J.-P., Hügle, B., Horneff, G., Neudorf, U., Lutz, T., Lilienthal, E., Kallinich, T., Tenbrock, K., Berendes, R., Niehues, T., Wittkowski, H., Weißbarth-Riedel, E., Heubner, G., Oommen, P., Klotsche, J., Foell, Dirk, Lainka, E.
Publicado no Pediatr Rheumatol Online J (2018)